185490 아이진
기본 정보
- 섹터: KOSDAQ:일반서비스
- 시가총액: 568억원 (2026-06-30 기준)
- 첫 등장: — (마커 미등장)
- 태그: 매크로/바이오헬스 · mRNA · 백신 · 유전자치료제 · 바이오 · 임상
- 네이버 금융: 🔗
기업개요
- 동사는 2000년 설립된 의학 및 약학 연구개발을 주사업으로 하는 바이오 벤처기업으로, 2015년 코스닥에 상장함.
- 단백질체학 및 면역학 연구로 시작하여, 현재는 GCT 기술을 기반으로 mRNA 백신과 AAV 유전자 치료제 개발을 추진하고 있음.
- 종속회사로 호주 임상 수행을 위한 EyeGene Australia와 mRNA 항암백신 및 단백질 대체 요법 치료제 개발사 레나임을 보유하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | 1,522 | 1,529 | 🔴 +0.46% | — | ×1.1 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.0 | +0.0 | -0.5 | +0.0 |
| 2026-07-13 | 1,532 | 1,522 | 🔵 -0.65% | — | ×1.7 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | +0.0 | +0.0 | -0.7 | +0.0 |
| 2026-07-10 | 1,440 | 1,532 | 🔴 +6.39% | — | ×0.8 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | +0.0 | +0.0 | -0.4 | +0.0 |
| 2026-07-09 | 1,440 | 1,440 | ⚪ +0.00% | — | ×1.1 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | +0.0 | -0.3 | +0.0 |
| 2026-07-08 | 1,425 | 1,440 | 🔴 +1.05% | — | ×0.9 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.2 | +0.0 |
| 2026-07-07 | 1,378 | 1,425 | 🔴 +3.41% | — | ×1.4 | ⚫ 그외 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-06 | 1,333 | 1,378 | 🔴 +3.38% | — | ×0.7 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-03 | 1,324 | 1,333 | 🔴 +0.68% | — | ×0.7 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | -0.0 | +0.0 | -0.1 | -0.2 |
| 2026-07-02 | 1,346 | 1,324 | 🔵 -1.63% | — | ×0.8 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | -0.0 | +0.0 | +0.4 | -0.8 |
| 2026-07-01 | 1,316 | 1,346 | 🔴 +2.28% | — | ×0.4 | ⚫ 그외 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.2 | +0.1 |
| 2026-06-30 | 1,346 | 1,316 | 🔵 -2.23% | — | ×0.3 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.0 | +0.3 | +0.0 |
| 2026-06-29 | 1,280 | 1,346 | 🔴 +5.16% | — | ×0.6 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | +0.0 | +0.0 | -0.8 | +0.0 |
| 2026-06-26 | 1,302 | 1,280 | 🔵 -1.69% | — | ×1.2 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.0 | +0.4 | +0.1 |
| 2026-06-25 | 1,302 | 1,302 | ⚪ +0.00% | — | ×0.7 | ⚫ 그외 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-24 | 1,309 | 1,302 | 🔵 -0.53% | — | ×0.5 | 🟡 금투 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-23 | 1,367 | 1,309 | 🔵 -4.24% | — | ×0.8 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.0 | -0.5 | +0.0 | |
| 2026-06-22 | 1,383 | 1,367 | 🔵 -1.16% | — | ×0.5 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.4 | -0.1 | |
| 2026-06-19 | 1,406 | 1,383 | 🔵 -1.64% | — | ×0.7 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.6 | -0.2 | |
| 2026-06-18 | 1,405 | 1,406 | 🔴 +0.07% | — | ×0.4 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | +0.9 | -0.0 | |
| 2026-06-17 | 1,399 | 1,405 | 🔴 +0.43% | — | ×0.6 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-16 | 1,405 | 1,399 | 🔵 -0.43% | — | ×0.5 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.3 | -0.1 | |
| 2026-06-15 | 1,432 | 1,405 | 🔵 -1.89% | — | ×0.5 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | +0.0 | +0.8 | +0.0 | |
| 2026-06-12 | 1,432 | 1,432 | ⚪ +0.00% | — | ×0.3 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.2 | -0.1 | |
| 2026-06-11 | 1,411 | 1,432 | 🔴 +1.49% | — | ×0.2 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -0.7 | +0.0 | |
| 2026-06-10 | 1,460 | 1,411 | 🔵 -3.36% | — | ×0.2 | 🔻 개인 | -1.2억 | -1.2 | +0.0 | +0.0 | +1.3 | -0.1 | |
| 2026-06-09 | 1,454 | 1,460 | 🔴 +0.41% | — | ×0.1 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.3 | -0.1 | |
| 2026-06-08 | 1,480 | 1,454 | 🔵 -1.76% | — | ×0.1 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | +0.4 | +0.4 | |
| 2026-06-05 | 1,505 | 1,480 | 🔵 -1.66% | — | ×0.1 | 🔻 개인 | -1.3억 | -1.3 | +0.0 | +0.0 | +1.2 | +0.0 | |
| 2026-06-04 | 1,523 | 1,505 | 🔵 -1.18% | — | ×0.1 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | -0.0 | +0.9 | -0.1 | |
| 2026-06-02 | 1,637 | 1,523 | 🔵 -6.96% | — | ×0.1 | 🟡 금투 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.0 | -0.0 | |
| 2026-06-01 | 1,710 | 1,637 | 🔵 -4.27% | — | ×0.1 | 🟢 외인 | +1.9억 | +1.9 | +0.0 | +0.0 | -1.9 | +0.1 | |
| 2026-05-29 | 1,779 | 1,710 | 🔵 -3.88% | — | ×0.2 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | -0.0 | |
| 2026-05-28 | 1,906 | 1,779 | 🔵 -6.66% | — | ×0.2 | 🟢 외인 | +3.0억 | +3.0 | +0.0 | -0.0 | -4.0 | +1.0 | |
| 2026-05-27 | 2,055 | 1,906 | 🔵 -7.25% | — | ×0.5 | 🟢 외인 | +1.6억 | +1.6 | +0.0 | +0.0 | -1.9 | +0.3 | |
| 2026-05-26 | 2,130 | 2,055 | 🔵 -3.52% | — | ×1.5 | 🔻 개인 | -1.8억 | -1.8 | +0.0 | -0.0 | +2.1 | -0.3 | |
| 2026-05-22 | 2,315 | 2,130 | 🔵 -7.99% | — | ×2.1 | 🔻 개인 | -12.8억 | -12.8 | +0.0 | +0.0 | +13.0 | -0.2 |
일자별 사유 (최신 위)
2026-07-10
- 사유: —
- 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +73.5억)
- 매크로 원인: 공통 촉매보다 신약개발·특허·제휴 등 종목별 개별 바이오 재료가 각각 부각됨 (보통)